Effects of Methimazole vs Propylthiouracil in Newborns: A Comparative Review.

aplasia cutis birth defects fetal harm graves disease hyperthyroidism methimazole propylthiouracil teratogen

Journal

Cureus
ISSN: 2168-8184
Titre abrégé: Cureus
Pays: United States
ID NLM: 101596737

Informations de publication

Date de publication:
Jul 2023
Historique:
received: 11 06 2023
accepted: 06 07 2023
medline: 8 8 2023
pubmed: 8 8 2023
entrez: 8 8 2023
Statut: epublish

Résumé

Hyperthyroidism is more common in women and the sensitivity of thyroid function changes during pregnancy. Excess levels of thyroid hormones and thioamides have a major impact on maternal and fetal outcomes. Our aim was to perform an extensive literature review and provide relevant details concerning the analytical and clinical aspects of the potential effects of the two main drugs used (methimazole and propylthiouracil) in newborns. A thorough literature review was conducted using PubMed and Google Scholar databases. In total, 10 relevant studies were identified and data from these studies were extracted and then extrapolated into results after analysis. Three out of four studies that used methimazole and carbimazole, one and two, respectively, showed adverse fetal outcomes requiring surgical management for congenital anomalies like aplasia cutis, patent vitellointestinal duct, and gastroschisis. Out of the three studies that used propylthiouracil, one baby underwent surgery for bilateral pyelectasis, vesicovaginal fistula, anal stenosis, and polydactyly. The findings of the aforementioned studies provide enough evidence to imply that the use of methimazole and carbimazole to treat antenatal hyperthyroidism has worse fetal outcomes than the use of propylthiouracil. Also, given the paucity of data in the existing literature regarding propylthiouracil's effects on newborns, further studies in this demographic are needed.

Identifiants

pubmed: 37551246
doi: 10.7759/cureus.41505
pmc: PMC10404379
doi:

Types de publication

Journal Article Review

Langues

eng

Pagination

e41505

Informations de copyright

Copyright © 2023, Bhagat et al.

Déclaration de conflit d'intérêts

The authors have declared that no competing interests exist.

Références

Am J Case Rep. 2021 Dec 21;22:e934417
pubmed: 34930889
J Clin Transl Endocrinol. 2019 Apr 12;16:100190
pubmed: 31049292
Int J Womens Health. 2016 Sep 19;8:497-504
pubmed: 27698567
J Endocr Soc. 2021 Jan 07;5(4):bvab001
pubmed: 33733018
Am J Case Rep. 2020 Sep 08;21:e926310
pubmed: 32898128
Obstet Gynecol Surv. 2022 Jan;77(1):45-62
pubmed: 34994394
Curr Pharm Biotechnol. 2011 May;12(5):774-80
pubmed: 21342119
Lancet. 2016 Aug 27;388(10047):906-918
pubmed: 27038492
Endocrinol Metab Clin North Am. 2007 Sep;36(3):617-56, v
pubmed: 17673122
J Dtsch Dermatol Ges. 2022 Feb;20(2):223-226
pubmed: 35146881
Lancet. 1980 Apr 5;1(8171):736-7
pubmed: 6103158
Case Rep Womens Health. 2018 Sep 26;20:e00081
pubmed: 30294557
Am J Med Genet A. 2008 Sep 15;146A(18):2390-5
pubmed: 18698631
Endocr J. 2017 Feb 27;64(2):157-162
pubmed: 27784851
Neurol India. 2006 Sep;54(3):312-3
pubmed: 16936401
QJM. 2012 Feb;105(2):189-93
pubmed: 21258054
Clin Obstet Gynecol. 2019 Jun;62(2):320-329
pubmed: 31026230
Turk Pediatri Ars. 2019 Jul 11;54(2):133-136
pubmed: 31384150
Eur Rev Med Pharmacol Sci. 2017 Apr;21(8):1932-1937
pubmed: 28485783
Endocrinol Nutr. 2013 Nov;60(9):535-43
pubmed: 23477757
Nat Rev Endocrinol. 2018 May;14(5):301-316
pubmed: 29569622
Endocr J. 2013;60(12):1281-7
pubmed: 24025611
Lancet Diabetes Endocrinol. 2013 Nov;1(3):238-49
pubmed: 24622372
Cureus. 2022 May 7;14(5):e24808
pubmed: 35686264
J Endocrinol Invest. 2015 Sep;38(9):977-85
pubmed: 25840794
Eur Thyroid J. 2012 Apr;1(1):30-3
pubmed: 24782995
Am Fam Physician. 2005 Aug 15;72(4):623-30
pubmed: 16127951
Obstet Gynecol. 2006 Feb;107(2 Pt 1):337-41
pubmed: 16449121
Iran J Pharm Res. 2019 Fall;18(Suppl1):1-12
pubmed: 32802086
Endocrinol Nutr. 2009 Feb;56(2):85-91
pubmed: 19627716
Ultrasound Obstet Gynecol. 2004 Feb;23(2):198-201
pubmed: 14770404
J Clin Endocrinol Metab. 2021 Mar 8;106(3):883-892
pubmed: 33349844
Endocr Pract. 2021 Mar;27(3):254-260
pubmed: 33588063
Can Fam Physician. 2009 Jul;55(7):701-3
pubmed: 19602653
J Clin Med. 2023 Feb 24;12(5):
pubmed: 36902600
J Clin Endocrinol Metab. 2016 Apr;101(4):1606-14
pubmed: 26815881
Medicine (Baltimore). 2018 Jan;97(3):e9606
pubmed: 29504986
Nat Clin Pract Endocrinol Metab. 2007 Jun;3(6):470-8
pubmed: 17515891
Thyroid. 2016 Oct;26(10):1343-1421
pubmed: 27521067
Physiol Rev. 2014 Apr;94(2):355-82
pubmed: 24692351
BMJ Clin Evid. 2015 Jan 21;2015:
pubmed: 25614153
Med Sci Monit. 2011 Apr;17(4):RA85-91
pubmed: 21455118
Nat Rev Endocrinol. 2022 Mar;18(3):158-171
pubmed: 34983968
Clin Endocrinol (Oxf). 2022 Jun;96(6):857-868
pubmed: 34845757
Thyroid. 2017 Mar;27(3):315-389
pubmed: 28056690

Auteurs

Mehak Bhagat (M)

Internal Medicine, Government Medical College, Amritsar, IND.

Purnima Singh (P)

College of Medicine, Gulf Medical University, Ajman, ARE.

Sindhu Meghana Sunkara (SM)

Internal Medicine, Caribbean Medical University, Curacao, CAN.

Merin T Abraham (MT)

Internal Medicine, Kasturba Medical College, Manipal, IND.

Maria Jimena Barroso Alverde (MJ)

Internal Medicine, Anahuac University, Mexico City, MEX.

Sravya R Mundla (SR)

Medicine, Apollo Institute of Medical Sciences and Research, Hyderabad, IND.

Andrea Mizrahi Drijanski (A)

Internal Medicine, Anahuac University, Mexico City, MEX.

Anna Jobilal (A)

Internal Medicine, Sri Ramaswamy Memorial Medical College Hospital and Research Center, Chennai, IND.

Mohit Lakkimsetti (M)

Internal Medicine, Mamata Medical College, Khammam, IND.

Nandini Nair (N)

Internal Medicine, Byramjee Jeejeebhoy Government Medical College, Pune, IND.

Waleed Razzaq (W)

Internal Medicine, Services Hospital Lahore, Lahore, PAK.

Zain U Abdin (ZU)

Medicine, District Head Quarter Hospital, Faisalabad, PAK.

Ishita Gupta (I)

Medicine, Dr. Rajendra Prasad Government Medical College, Tanda, IND.

Classifications MeSH